(Q36654316)

15 August 2017

1 reference

title

Can statins put the brakes on Alzheimer's disease? (English)

1 reference

15 August 2017

0 references

James F Whitfield

1

1 reference

PubMed ID

17107274

15 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

Expert Opinion on Investigational Drugs

15 August 2017

1 reference

15 August 2017

15

1 reference

15 August 2017

12

1 reference

15 August 2017

1479-1485

1 reference

Oxysterols and Alzheimer's disease.

15 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Cholesterol in Alzheimer's disease and tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Statins and the risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Cholesterol and 24S-hydroxycholesterol trafficking in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

The role of cholesterol and statins in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Cholesterol in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

The link between cholesterol and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Cholesterol and Alzheimer's disease--is there a relation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Statin therapy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Cholesterol, statins and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Re-assessing the relationship between cholesterol, statins and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Statins inhibit the dimerization of beta-secretase via both isoprenoid- and cholesterol-mediated mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Molecular, endocrine, and genetic mechanisms of arterial calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Processing of amyloid precursor protein as a biochemical link between atherosclerosis and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Effect of pravastatin on plasma sterols and oxysterols in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Isoprenoids and Alzheimer's disease: a complex relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Neurovascular regulation in the normal brain and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Atherosclerosis of cerebral arteries in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

An association with great implications: vascular pathology and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Lipid rafts: bringing order to chaos

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

The involvement of lipid rafts in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Association of active gamma-secretase complex with lipid rafts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

The players on the gamma-secretase team

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Isoprenoids as mediators of the biological effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Alzheimer's disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Cell cycle regulatory failure in neurones: causes and consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

The cell cycle as a therapeutic target for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Pathophysiology of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Glycogen synthase kinase 3beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Vicious cycles within the neuropathophysiologic mechanisms of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Axonal transport and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Intracellular and extracellular Abeta, a tale of two neuropathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Clearing the brain's amyloid cobwebs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Beta-amyloid activated microglia induce cell cycling and cell death in cultured cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Pinpointing plaques with PIB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

New Insights Into the Molecular Mechanisms of Action of Bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

Bisphosphonates and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.12.1479

10.1517/13543784.15.12.1479

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17107274